What is BUDFF's health score?

Anheuser-Busch InBev SA/NV (BUDFF) has a TradeApes health score of 52 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BUDFF's estimated fair value?

Based on our 5-year discounted cash flow model, Anheuser-Busch InBev SA/NV's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BUDFF undervalued or overvalued?

Our model currently rates BUDFF as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BUDFF... Refresh in a moment for the full analysis.

Anheuser-Busch InBev SA/NV (BUDFF)

Consumer Defensive Inconclusive inconclusive mixed

Updated: 2026-06-06

TradeApes Score

Financial Strength

35 Weak

Operating Trend

60 Healthy

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Weak liquidity — current assets below current liabilities

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.